Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenneth D'entremont Insider Profile
4 Followers
Kenneth D'entremont, Chief Executive Officer at Medexus Pharmaceuticals Inc, holds 1.48M shares in Medexus Pharmaceuticals Inc (Ticker: TSE:MDP). Most recently, Kenneth D'entremont Bought C$3,000 shares of Medexus Pharmaceuticals Inc on Sep 25, 2024 for an estimated value of 7.50K.
Kenneth D'entremont Medexus Pharmaceuticals Inc (MDP)Chief Executive Officer
Medexus Pharmaceuticals Inc (MDP)
Chief Executive Officer
Ranked #8,461 out of 99,218 Corporate Insiders
Profitable Transactions
10 out of 24 Profitable Transactions
Average Return
+11.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kenneth D'entremont's holdings
Insider Roles
Chief Executive Officer
Roles that Kenneth D'entremont holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 25, 2020 - Mar 25, 2021
Return:+269.70%
The most profitable trade made by Kenneth D'entremont
Kenneth D'entremont's Trading History
List of latest transactions for each holding click on a transaction to see Kenneth D'entremont's performance on stock
You May Also Like
Kenneth D'entremont insider profile FAQ
What is the percentage of profitable transactions made by Kenneth D'entremont?
The percentage of profitable transactions made by Kenneth D'entremont is 42%.
What is the average return per transaction made by Kenneth D'entremont?
The average return per transaction made by Kenneth D'entremont is 11.70%.
What stocks does Kenneth D'entremont hold?
Kenneth D'entremont holds: TSE:MDP stocks.
What was Kenneth D'entremont’s latest transaction?
Kenneth D'entremont latest transaction was an Informative Buy of C$7.50K.
What was Kenneth D'entremont's most profitable transaction?
Kenneth D'entremont’s most profitable transaction was an Informative Buy of TSE:MDP stock on March 25, 2020. The return on the trade was 269.70%.
What is Kenneth D'entremont's role in Medexus Pharmaceuticals Inc?
Kenneth D'entremont's role in Medexus Pharmaceuticals Inc is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.